M1

Cards (212)

  • Immunology is the study of immunity, which is the resistance to infectious diseases.
  • Immunity is the major function of the Immune System
  • The Immune System is structured to recognize, respond to, and destroy invading microorganisms like bacteria, viruses, fungi, and parasites
  • Survivors of common infectious diseases in the past rarely contracted the disease again, rooted to the development of the science of immunology
  • Immunology consists of:
    • The study of molecules, cells, organs, and systems responsible for recognizing and disposing of foreign material
    • How body components respond and interact
    • Desirable and undesirable consequences of immune interactions
    • Ways in which the immune system can be manipulated to protect against or treat disease
  • Significant milestones in immunology include:
    • Edward Jenner's smallpox vaccination in 1798
    • Louis Pasteur's live, attenuated chicken cholera and anthrax vaccines in 1880-1881
    • Elie Metchnikoff's cellular theory of immunity through phagocytosis in 1883-1905
    • Robert Koch's demonstration of cutaneous hypersensitivity in 1891
    • Jules Bordet's discovery of complement in 1894
    • Paul Ehrlich's antibody formation theory in 1900
    • Charles Richet and Paul Portier's discovery of immediate-hypersensitivity and anaphylaxis in 1902
    • Adaptive immunity: characterized by specificity for each pathogen and ability to remember prior exposure
    • Adjuvant: substance that enhances and potentiates the immune response
    • Adoptive immunity: results from transferring immune cells from an immunized host to a nonimmune individual
    • Affinity: initial force of attraction between an antibody and antigen
  • Terms in immunology:
    • Accelerated rejection: occurs within 1 to 5 days after second exposure to tissue antigens
    • Acquired immunodeficiency syndrome (AIDS): caused by HIV affecting the immune system
    • Active immunity: results from natural exposure to an infectious agent or vaccine
    • Acute graft-versus-host disease (GVHD): occurs shortly after immunocompetent cells are transplanted, characterized by skin rashes, diarrhea, and increased susceptibility to infection
    • Acute rejection (AR): occurs days to weeks after transplantation due to cellular mechanisms and antibody formation
  • Agglutination inhibition:
    • Based on competition between antigen-coated particles and soluble patient antigens for a limited number of antibody-combining sites
    • Lack of agglutination is a positive test result
  • Agglutinin:
    • An antibody that causes clumping or agglutination of the cells that triggered its formation
  • Allergen:
    • An antigen that triggers a type I hypersensitivity response (i.e., an allergy)
  • Alloantigen:
    • An antigen found in another member of the host’s species and capable of eliciting an immune response in the host
  • Allograft:
    • Tissue transferred from an individual of one species into another individual of the same species
  • Allotype:
    • A minor variation in amino acid sequence in a particular class of immunoglobulin molecule that is inherited in Mendelian fashion
  • Alternative pathway:
    • Means of activating complement proteins without an antigen-antibody combination
    • Triggered by constituents of microorganisms
  • Amplicon:
    • A copy of a select portion of DNA obtained by the polymerase chain reaction (PCR)
  • Amplification:
    • Copying of nucleic acids to increase the amount available for testing
  • Analyte:
    • The substance being measured in an immunoassay
  • Analytic sensitivity:
    • The lowest measurable amount of an analyte
  • Analytic specificity:
    • An assay’s ability to generate a negative result when the analyte is not present
  • Anaphylatoxin:
    • A small peptide formed during complement activation that causes increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils and mast cells
  • Anaphylaxis:
    • A life-threatening response to an allergen characterized by the systemic release of histamine
  • Anergy:
    • A state of immune unresponsiveness to a specific antigen
  • Antagonism:
    • When the action of one cytokine counteracts the activity of another cytokine
  • Antibodies:
    • Glycoproteins produced by B lymphocytes and plasma cells in response to foreign substance exposure
    • Also known as immunoglobulins
  • Antibody-dependent cell cytotoxicity (ADCC):
    • The process of destroying antibody-coated target cells by natural killer cells, monocytes, macrophages, and neutrophils, all of which have specific receptors for an antibody
  • Antibody-drug conjugates:
    • Antibody attached to toxins or radioisotopes to help specifically destroy cancer cells
  • Antigen:
    • Macromolecule capable of eliciting formation of immunoglobulins (antibodies) or sensitized cells in an immunocompetent host
  • Antigen-dependent phase:
    • The final phase of B-cell development, which occurs when a B cell is stimulated by an antigen and undergoes transformation to a blast stage, resulting in the formation of memory cells and antibody-secreting plasma cells
  • Antigen-independent phase:
    • The first phase of B-cell development in the bone marrow, resulting in mature B cells that have not yet been exposed to antigen
  • Antigen presentation:
    • The process by which degraded peptides within cells are transported to the plasma membrane with MHC molecules so T cells can then recognize them
  • Antitoxin:
    • Antibody used in passive immunization for the purpose of neutralizing a bacterial toxin
  • Apoptosis:
    • Programmed cell death
  • Arthus reaction:
    • A type III hypersensitivity skin reaction that occurs when an animal has a large amount of circulating antibody and is exposed to the antigen intradermally, resulting in localized deposition of immune complexes
  • Atopy:
    • An inherited tendency to respond to naturally occurring allergens, resulting in the continual production of IgE
  • Attenuation:
    • Process of producing nonpathogenic bacteria or viruses for use in vaccines
    • Organisms weakened by treatment with a chemical, exposure to elevated or cold temperatures, or repeated in vitro passage in cell culture
  • Autoantibody:
    • An antibody produced against an antigen found on an individual’s own cells, tissues, or organs
  • Autoantigen:
    • An antigen that belongs to the host and is not capable of eliciting an immune response under normal circumstances
  • Autograft:
    • Tissues removed from one area of an individual’s body and reintroduced in another area of the same individual
  • Autoimmune disease:
    • Condition in which damage to body organs results from the presence of autoantibodies or autoreactive cells